carbamazepine has been researched along with tanespimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Meng, QW; Sui, GJ; Sun, LC; Xi, YH; Zhao, CH | 1 |
Cai, L; Chen, X; Meng, Q; Sui, G; Sun, L; Zhao, C | 1 |
2 other study(ies) available for carbamazepine and tanespimycin
Article | Year |
---|---|
[Enhancement of HER-2 degradation by carbamazepine in breast cancer SKBR-3 cell line].
Topics: Acetylation; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzoquinones; Blotting, Western; Breast Neoplasms; Carbamazepine; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trastuzumab | 2006 |
Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90.
Topics: Acetylation; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Breast Neoplasms; Carbamazepine; Cell Line, Tumor; Cell Proliferation; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Female; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Leupeptins; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Protein Stability; Receptor, ErbB-2; RNA, Messenger; Time Factors; Trastuzumab; Tubulin | 2011 |